European Heart Journal Advance Access published online on July 3, 2006
European Heart Journal, doi:10.1093/eurheartj/ehl128
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cardiac Catheterisation Laboratory, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, DK-2100, Denmark
* To whom correspondence should be addressed.
Editorial
Epo cytokine-doping of heart disease patients, will it work?
Erik Jørgensen 1 *,
Lene Bindslev 2,
Rasmus Sejersten Ripa 1,
and
Jens Kastrup 3
2 Cardiac Stem Cell Research Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
3 Cardiac Catheterisation Laboratory, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, DK-2100, Denmark; Cardiac Stem Cell Research Laboratory, University Hospital Rigshospitalet, Copenhagen, Denmark
Erik Jørgensen, E-mail: erikj{at}rh.dk
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Minetti, L. Agati, and W. Malorni The microenvironment can shift erythrocytes from a friendly to a harmful behavior: Pathogenetic implications for vascular diseases Cardiovasc Res, July 1, 2007; 75(1): 21 - 28. [Abstract] [Full Text] [PDF] |
||||
